This whitepaper outlines a practical framework for designing scientifically justified, regulatory-ready IND packages that ...

Welcome to the Weekly Rundown where the DDN editors cover this week’s top biotech and pharma news.

BCG vaccination reduced tau pathology and neuroinflammation in mice, prompting researchers to investigate whether trained immunity could inform future treatments for Alzheimer’s disease.

Discover how researchers are looking beyond individual neurons to understand how genetic variations shape activity across ...

Explore how dual binding assays reveal interactions between bispecific antibodies and their targets, providing insights into ...

Advances in biolayer interferometry enable the analysis of small molecule interactions, providing new insights into binding kinetics and affinity.

The first proof-of-concept study showed that the gene therapy reduced the production of cerebrospinal fluid in the brains of ...

Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.

Monocarboxylate transporter 8 (MCT8) deficiency, also known as Allan–Herndon–Dudley syndrome (AHDS), is a rare X-linked disorder characterized by two simultaneous and opposing thyroid hormone crises ...

A new experimental drug could finally turn multiple sclerosis (MS) from a disease that has no cure to one that can be successfully reversed with treatment. Researchers led by Jayakrishna Ambati at the ...

Mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome Type A, progressively destroys cognitive and motor function in early childhood through a single missing enzyme: ...

The global clinical trial supplies market was valued at $4.31 billion in 2025 and is projected to reach $6.73 billion by 2031, growing at a compound annual growth rate of 7.92 percent. That growth is ...